EUDA CFO files initial Form 3 ownership report

EUDA Health Holdings Ltd Chief Financial Officer Tay Whye Shin has filed an initial Form 3, which is a required statement of beneficial ownership for company insiders.

Rhea-AI Filing Summary

EUDA Health Holdings Ltd Chief Financial Officer Tay Whye Shin has filed an initial Form 3, which is a required statement of beneficial ownership for company insiders. The filing establishes this officer’s reporting status under SEC rules but does not report any stock transactions.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does EUDA Health (EUDA) CFO Tay Whye Shin’s Form 3 filing show?

The filing shows that EUDA Health’s Chief Financial Officer, Tay Whye Shin, has formally reported insider status on Form 3. It serves as an initial statement of beneficial ownership and contains no reported stock transactions in this submission.

Are there any buy or sell transactions in EUDA Health (EUDA) CFO’s Form 3?

No, the Form 3 for EUDA Health’s Chief Financial Officer reports no buy, sell, acquisition, or disposition transactions. It functions purely as an initial ownership disclosure required when an executive becomes subject to SEC insider reporting.

Why is EUDA Health (EUDA) Chief Financial Officer required to file Form 3?

Form 3 is required when someone becomes an officer, director, or significant owner of a public company. EUDA Health’s Chief Financial Officer, Tay Whye Shin, must file it to disclose beneficial ownership and begin ongoing SEC insider reporting obligations.

Does EUDA Health (EUDA) CFO’s Form 3 indicate any derivative securities activity?

No, the data show no derivative security transactions or holdings reported for EUDA Health’s Chief Financial Officer in this Form 3. The derivative transaction count and exercise-related metrics are all zero in the filing’s summarized information.

What does the transaction summary in EUDA Health (EUDA) CFO’s Form 3 indicate?

The transaction summary indicates zero buys, sells, acquisitions, dispositions, gifts, tax withholdings, or restructurings. For EUDA Health’s Chief Financial Officer, this Form 3 serves as a baseline ownership report without any trading activity included.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 04:17 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Tay Whye Shin

(Last) (First) (Middle)

60 KAKI BUKIT PLACE, #03-01

(Street)

EUNOS TECHPARK 415979

(City) (State) (Zip)

SINGAPORE

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
EUDA Health Holdings Ltd [ EUDA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	/s/ Whye Shin Tay	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)